Visit COVID-19 resources

[Skip to Content]

Clinical Guidelines

Serum-Eye-Drops-Guideline-2017

Serum-Eye-Drops-Guideline-2017

This guideline sets out defined criteria for the use of Serum Eye Drops, monitoring of clinical and patient-reported outcomes to improve patient morbidity and standards of care.

  • 19 October 2020

Commissioning-Guidance-Process-Manual-2017

Jul 20
2018

This process manual details the process by which commissioning guidance is developed by the RCOphth to ensure consistency and provide users with assurance that the appropriate methodologies and strategies have been adopted in the development of the guidance.

  • 20 July 2018

Serum Eye Drops Guideline Lay Summary

Nov 23
2017

Dry eye disease is a global public-health problem with significant impact on quality of life. Serum Eye Drops (SED) contain many nutritional factors that aid therapeutics. Across the NHS There is variation in practice, inequality of access to SED service and no regulated monitoring outcome. This guideline sets out defined criteria for the use of Serum Eye Drops, monitoring of clinical and patient-reported outcomes to improve patient morbidity and standards of care.

  • 23 November 2017

Serum Eye Drops Guideline Executive Summary

Nov 23
2017

Recommendations table for Serum Eye Drops Guideline

  • 23 November 2017

Guidelines for Screening for Uveitis in Juvenile Idiopathic Arthritis (JIA)

Aug 09
2017

Guidelines for Screening for Uveitis in Juvenile Idiopathic Arthritis (JIA)
Produced jointly by BSPAR and the RCOphth 2006

  • 9 August 2017